Medical News

RSS

Significant progress on international development strategy for stem cell-derived human corneal tissue

International Stem Cell Corporation, www.intlstemcell.com, today announced significant progress on its international development strategy for stem cell-derived human corneal tissue. Such tissue can potentially be used to replace cadaver-derived corneas in treatment of severe corneal vision impairment and to eliminate the need to use live animals in safety testing of drugs, chemicals and consumer products.

25 May 2010

GATOR approach helps assess health information websites

Patients researching health conditions on the internet should use reputable and frequently updated websites and not see online research as a replacement for consulting healthcare professionals, according to a paper in the May issue of the Journal of Clinical Nursing.

25 May 2010

New campaign to raise awareness about soul wrenching realities of Alzheimer's disease

The Alzheimer Society is launching a new campaign in an effort to raise awareness about the soul wrenching realities of Alzheimer's disease, and the Society's efforts to fund research towards a cure.

25 May 2010

Clovis Oncology, Avila Therapeutics announce development agreement for NSCLC EMSI program

Clovis Oncology, Inc., a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents, and Avila Therapeutics, Inc., a biotechnology company designing targeted covalent drugs, announced today an agreement for the development and commercialization of Avila's epidermal growth factor receptor (EGFR) mutant-selective inhibitor (EMSI) program, currently in pre-clinical development for the treatment of non-small cell lung cancer (NSCLC).

25 May 2010

Sonomax Technologies signs collaboration agreement with DEC

Sonomax Technologies Inc. is pleased to announce that is has signed a collaboration agreement with the Dynamic Ear Company. DEC is a leading manufacturer and developer of innovative in-ear products that permit users to control the volume of external sound that reaches their ears, which by doing so, contribute to hearing safety and a comfortable sound experience.

25 May 2010

Yissum introduces Dralgo platform to accelerate discovery of promising drug candidates

Drug discovery and development is a highly risky process, with only one in 10,000 initial candidate compounds reaching the market. When taking into account the aborted candidates, the cost of developing one successful drug may even reach $1 billion, and the development process may take as long as 15-20 years.

25 May 2010

Consumer Reports Health rates four spray-on sunscreens

Memo to beach bums: get ready to pump it and spray it, and don't apply it in the wind. New tests of sunscreens by Consumer Reports Health reveal that four spray-on sunscreens provided the best protection from the sun's Ultraviolet A (UVA) and Ultraviolet B (UVB) rays. The ratings are available in the July issue of the magazine. The magazine also looks at insect repellents. Both articles are available in Spanish on www.consumerreportsenespanol.org.

25 May 2010

Researchers study how hematopoietic cells react when Epo levels increase

Our body reacts to blood loss by stimulating the production of red blood cells (erythrocytes). The cells of the hematopoietic (blood-forming) system in the bone marrow do so upon receipt of a signal by a hormone called erythropoietin, or Epo for short. This hormone is produced mainly by the kidney that increases the Epo level by up to a thousand-fold as a response to falling oxygen saturation of the blood.

25 May 2010

Botvin LST Parent Program now available as e-book

The award-winning Botvin LifeSkills Training Parent Program is now available as an e-book: Princeton Health Press announced today its plan to make parent resources more accessible through the world's most popular eReader, Amazon's Kindle, as well as through the Kindle application for PCs, Mac, Blackberry and the Apple iPhone and iPad.

25 May 2010

ImmunoGen to present clinical data on IMGN388 solid tumor compound at 2010 ASCO

ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, announced today that there will be several clinical data presentations for compounds utilizing the Company's Targeted Antibody Payload (TAP) technology at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO) being held in Chicago on June 4-8, 2010.

25 May 2010

Nutritious gluten-free breads for coeliac disease patients

Researchers at Teagasc Food Research Ashtown are producing tasty, nutritious gluten-free breads for coeliac disease sufferers. The research focused on using the so-called 'pseudocereals' amaranth, quinoa and buckwheat to replace wheat in bread formulations. These cereals are gluten-free, and are also rich in nutrients; therefore, their incorporation in the gluten-free diet could not only add variety but also improve nutritional quality.

25 May 2010

Epeius Biotechnologies announces Phase I/II study results of Rexin-G and Reximmune-C for cancer immunotherapy

Epeius Biotechnologies Corporation today announces the clinical results of the study entitled "A Phase I/II Study of Intravenous Rexin-G and Reximmune-C for Cancer Immunotherapy: The GeneVieve Protocol" at the ASCO Annual Meeting on June 6, 2010. The presentation will be made by Dr. Jorge G. Ignacio, Chairman of the Cancer Institute and Bioethics Committee-Philippine General Hospital, and Principal Investigator of the study.

25 May 2010

DeCare Dental introduces International Emergency Dental Program

DeCare Dental, a global dental benefit management company and a wholly owned subsidiary of WellPoint, Inc., is pleased to introduce the International Emergency Dental Program – a service that gives dental members and their covered dependents access to emergency dental care from credentialed dentists around the world.

25 May 2010

NovaBay Pharmaceuticals completes enrollment in Phase 2a trial of NVC-422 for treatment of impetigo

NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, today announced the completion of enrollment in a Phase 2a proof-of-concept trial for the treatment of impetigo.

25 May 2010

Hawaii Pacific Health, Saint Barnabas Health Care System and XCelience achieve CEO Cancer Gold Standard

Hawaii Pacific Health, Saint Barnabas Health Care System N.J., and XCelience LLC, have received CEO Cancer Gold Standard™ accreditation, recognizing the commitment of these organizations to reducing the risk of cancer for employees and their families by promoting healthy lifestyle choices, encouraging early detection through cancer screenings, and ensuring access to quality treatment.

25 May 2010

Researchers develop new device that can change current landscape of chronic wound management

Complex wounds affect more patients in the United States than heart attack and stroke combined, and five to seven million Americans with complex wounds account for over $20 billion in healthcare expenditures. About 150,000 amputations a year result from complex wounds, while about 80,000 are attributed to diabetes and peripheral arterial disease.

25 May 2010

AlphaMed Press earns CEO Cancer Gold Standard accreditation

AlphaMed Press has received CEO Cancer Gold Standard™ accreditation, recognizing the organization's commitment to taking concrete actions to reduce the cancer risk of its employees and their families through screenings, early detection, and healthy changes in lifestyle and in the workplace.

25 May 2010

Masimo PVI identifies patients at high risk for developing severe hypotension during anesthesia induction

Masimo, the inventor of Pulse CO-Oximetry and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that a new clinical study published in the May 2010 issue of Acta Anaesthesiologica Scandinavica shows that Masimo pleth variability index can be used to help clinicians assess risk for mean arterial pressure decreases and subsequent hypotension during anesthesia administration.

25 May 2010

USPTO issues composition of matter patent for Transave's ARIKACE

Transave Inc. today announced that the United States Patent and Trademark Office has issued an important composition of matter patent (U.S. Patent No. 7,718,189) for liposomal aminoglycoside formulations including its lead compound, ARIKACE™ (liposomal amikacin for inhalation). The company expects that the patent will provide exclusivity for ARIKACE until October 1, 2026.

25 May 2010

t2c001 product obtains certificate under EMA regulations for ATMPs

t2cure GmbH, a biopharmaceutical company developing and marketing stem cell-based regenerative therapies, announced today that the quality of its lead product t2c001 has been certified by the European Medicines Agency.

25 May 2010

Medical News

Significant progress on international development strategy for stem cell-derived human corneal tissue

GATOR approach helps assess health information websites

New campaign to raise awareness about soul wrenching realities of Alzheimer's disease

Clovis Oncology, Avila Therapeutics announce development agreement for NSCLC EMSI program

Sonomax Technologies signs collaboration agreement with DEC

Yissum introduces Dralgo platform to accelerate discovery of promising drug candidates

Consumer Reports Health rates four spray-on sunscreens

Researchers study how hematopoietic cells react when Epo levels increase

Botvin LST Parent Program now available as e-book

ImmunoGen to present clinical data on IMGN388 solid tumor compound at 2010 ASCO

Nutritious gluten-free breads for coeliac disease patients

Epeius Biotechnologies announces Phase I/II study results of Rexin-G and Reximmune-C for cancer immunotherapy

DeCare Dental introduces International Emergency Dental Program

NovaBay Pharmaceuticals completes enrollment in Phase 2a trial of NVC-422 for treatment of impetigo

Hawaii Pacific Health, Saint Barnabas Health Care System and XCelience achieve CEO Cancer Gold Standard

Researchers develop new device that can change current landscape of chronic wound management

AlphaMed Press earns CEO Cancer Gold Standard accreditation

Masimo PVI identifies patients at high risk for developing severe hypotension during anesthesia induction

USPTO issues composition of matter patent for Transave's ARIKACE

t2c001 product obtains certificate under EMA regulations for ATMPs

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News